Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma

  • Meng Q
  • Liu Z
  • Maeurer M
  • et al.
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Meeting abstracts The generation of T lymphocytes with specific reactivity against autologous tumor cells is a prerequisite for effective targeted cellular therapies. We established a protocol for tumor infiltrating lymphocytes (TILs) cultures from small biopsies or surgically resected material

Cite

CITATION STYLE

APA

Meng, Q., Liu, Z., Maeurer, M., Rangelova, E., Ambati, A., Poiret, T., … Dodoo, E. (2015). Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma. Journal for ImmunoTherapy of Cancer, 3(Suppl 2), P35. https://doi.org/10.1186/2051-1426-3-s2-p35

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free